Clinical trial
Serratus Plane Block (SPB) Versus Capsaïcine Versus Botox-A for Chronic Neuropathic Pain in Post-mastectomy Syndrome
NCT06807164 is registered in ClinicalTrials.gov with Centre Oscar Lambret as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Serratus Plane Block (SPB) Versus Capsaïcine Versus Botox-A for Chronic Neuropathic Pain in Post-mastectomy Syndrome
- Lead sponsor
- Centre Oscar Lambret
- Phase
- Phase 2
- Overall status
- Withdrawn
- Start date
- June 10, 2025
- Completion date
- September 22, 2026
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
post-mastectomy neuropathic pain syndrome